www.thcl.com.au ASX RELEASE (16 th May 2017) PROACTIVE INVESTOR PRESENTATION The Hydroponics Company Limited ( ASX: THC ) is pleased to advise that Dr Andrew Beehag, Chief Executive Officer of Canndeo Limited, THC’s medicinal cannabis division, will be presenting at Proactive Investors’ Spotlight CEO Sessions Series in Melbourne today. In accordance with ASX Listing Rule 3.1 please see the attached updated Investor Presentation. Dr Beehag will also be presenting to investors in Sydney tomorrow, Wednesday 17th May. Henry Kinstlinger Company Secretary The Hydroponics Company Limited Level 2, 131 Macquarie Street, Sydney, NSW 2000 Australia P: +61 2 9251 7177 M: +61 418 613 028 E: henryk@thcl.com.au The Hydroponics Company Limited Level 2, 131 Macquarie Street, ACN: 614 508 039 (ASX:THC) Sydney, NSW, Australia. 2000 p: +61 2 9251 7177
ASX:THC A l e a d i n g , g l o b a l c a n n a b i s b u s i n e s s Investor Presentation May 2017
DISCLAIMER The material in this presentation ( ma material ) is not and does not Such statements relate to future events and expectations and, as such, constitute an offer, invitation or recommendation to subscribe involve known and unknown risks and uncertainties. Actual events and for, or purchase any security in The Hydroponics Company results may differ materially from those expressed or forecasted in Limited ( TH THC ) nor does it form the basis of any contract or forward-looking statements due to a number of factors. The principal commitment. THC makes no representation or warranty, express important risk factors that could cause THC’s actual performance and or implied, as to the accuracy, reliability or completeness of this future events and actions to differ materially from such forward-looking material. THC, its directors, employees, agents and consultants statements, include, but are not limited to, continuing volatility in the shall have no liability, including liability to any person by reason capital or credit markets and other changes in the securities and capital of negligence or negligent misstatement, for any statements, markets, changes in market prices of THC’s investments, the occurrence opinions, information or matters, express or implied, arising out of one or more catastrophic events, such as an earthquake, hurricane, of, contained in or derived from, or for any omissions from this or act of terrorism, changes in laws or regulations, changes in income material except liability under statute that cannot be excluded. tax laws, and changes in general economic and market factors that Statements contained in this material, particularly those affect the prices of securities or the industries in which it does business. regarding possible or assumed future performance, costs, This presentation includes certain statements, estimates and dividends, production levels or rates, prices, resources, reserves projections that rely upon various assumptions. Those assumptions may or potential growth of THC, industry growth or other trend or may not prove to be correct. The Presentation does not purport to projections are, or may be, forward looking statements. contain all the information that a prospective investor may require. The information may not be appropriate for all persons, and it is not possible for The Hydroponics Company Limited to have any regard to the investment objectives, financial situation and particular needs of each recipient who reads or uses this information. 2
THE HYDROPONICS COMPANY CANNABIS IS THE WORLD’S NEW HIGH GROWTH SECTOR Medi Medicina nal canna nnabi bis s di divisi sion n – New technol olog ogy in water pumps, , water pharmaceut pha eutical model del for Aus Australia pur purification n and nd canna nnabi bis s genet genetics targeting est. $100m market ta End-to En to-end end cover erage e of canna nnabi bis s ma markets with significant synergies Hydr Hy dropo poni nics s di divisi sion n with h more e tha han n 5 5 years profitable trading ye Mo More e tha han n 17 17 yea ears s of canna nnabi bis s growing gr ng exper perienc ence Greenhouse div Gr ivis isio ion enab ablin ling next- Po Positioned for future acquisitions ge generat ation indoor farming in internatio ionally ally 3
SHARE STRUCTURE The Hydroponics Company Limited at 15 May 2017 Share Price Sh Sh Shares on Issue Fr Free Trading Es Escrow owed ed Shares es Ma Market Cap Top 20% To Number of Nu Shares Sh Sh Shareholders TH THC: C: 34c 34c 5c 104.1 104.1 47.1 47.1 57.0 57.0 $35.4 $35.4 46.3% 46.3% 1450 1450 THCO: 11. TH 11.5c million mi million mi million mi mi million (I (IPO: : 752) ASX: THC 4
PORTFOLIO APPROACH TO CANNABIS Can Cannab abis is is is a a new inve in vestment sector Growth Gr Options fo Op for diversifi fication op oppor ortunities are • Self managed diversified Why Diversify? Wh globa gl bal and nd unev uneven en portfolio • ETF in medical marijuana Many Ma ny list sted ed compa pani nies es Mul Multipl ple e busi business ness types ypes ha have e no no rev evenue enue in in can annab abis is spac ace 5
PORTFOLIO APPROACH TO CANNABIS Continued Multiple sector Exposure to USA, Canada, exposure, each with Separate divisions for farm Central America, Europe, Expansion through new high growth potential establishment, growing supplies Australia technology introduction and medicinal cannabis Profitable Positioned for future hydroponics division acquisition and further 6 positive diversification
CANNABIS IS A THRIVING OPPORTUNITY US US USA Legal Cannabis market (medicinal + recreational) 29 US States + DC medicinal ca cannabis legalised estimated 7 US States recreational ma marijuana legalised US$20B by 2021 US 2021 Ca Canada US Cannabis-related estimated Medicinal ca cannabis legalised industry revenues 1 July 2018 le legis isla latio ion US$24B-US US US$44B in 2020 of recreational marijuana 89% of the US 89% Australia Au support doctor recommended medicinal cannabis Great demand po potent ential al 1. 1.8m 8m pa patient ents with neuropathic pain 7
CANNDEO Gr Growin ing & Extrac Ex actio ion Te Technology Converting unique intellectual property in cannabis breeds and Product Pr extraction technology to Future IP Fu De Development De Delivery approved products for the Research Re Me Metho hods ds Australian market Sa Sales of Aus Australian Pr Proprietary Manuf Ma nufactur uring ng Medicines Medi nes This division aims to lead the development of therapeutically superior, paramount quality and cost effective medicines derived from Ca Cannabis sa sativa. 8
A NEW CLASS OF MEDICINAL PRODUCTS Australia Clear strategy for bringing Collaborative R&D discovery medicinal cannabis to the projects for medicinal cannabis Australian market, estimated at $100 $100-400m 400m Target multiple markets with high purity cannabidiol (CBD) Pursuing a pharmaceutical Production under Government model licensing program A A ne new class of medi dicina nal pr produc ducts +17 years of Cannabi annabis sa sativa targeting dementia, neurological, breeding, variety selection and epilepsy and other disorders growth management 9
EPIGENETIC TECHNOLOGY IP Innovative Plant Breeding for accelerated growth and higher return Non GMO Selectively bred No foreign DNA Thrive under myriad introduced environmental stressors Grows 33% to 40% faster Stable Quicker and higher Ideal candidates for returns to breeders gene silencing 10
HYDROPONICS DIVISION Hydroponic equipment and nutrients Over 600 prod oducts, , 9 trademarks St Strong distribution 22% inc 22% ncrea ease se rev evenue enue 1st 1st Th The cornerstone networks Qtr 2017 Qt 2017 of of THC’s acq acquis isit itio ions Trading profita Tr tably New d Ne distribution across fo for 5+ years USA and Europe across Canada, UK, EU and USA 11
DISTRIBUTION MANUFACTURING Proprietary trademarked products include: Pr Lighting and power supplies • Lighting relays and Climate control • ned by THC 100% owned 100% Ventilation and Trimming • • Extraction bags Whole Wh lesale ale network in the US, Canada and UK • Plant rotation systems Strong sourcing and quality control te team in China Eyewear • Nutrients and accessories Fa Fast paced and innovative R&D Division with • increased resources offering considerable growth potential 12
NEW PRODUCTS IN 2017 Award winning systems, exclusive worldwide licence, international distribution rights SUPA-STELTH INNAWATER WATER STERILISATION WATER PUMPS AND CONDITIONER SYSTEMS Exclusive license for hydroponics Exclusive international marketing market distribution and distribution rights for hydroponic and indoor farming Innovative pumps that minimise electricity consumption Award winning chemical free water purification systems 13
ADVANCED HYDROPONIC GREENHOUSES A&B Hydr A& Hydropo poni nics s is a world leader in the field of TH THC has also secured the exclusive services of hydroponics, specializing in the design and agronomist Jim Barlow to represent THC manufacture of the finest commercial hydroponic throughout the Americas to develop large greenhouses and growing systems available for any commercial hydroponic greenhouses type of environment 14
Recommend
More recommend
